HFM
IONS icon

Harvest Fund Management’s Ionis Pharmaceuticals IONS Stock Holding History

Harvest Fund Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Hold
234
– – ﹤0.01% 407
2026
Q1 		$18K Sell
234
-4,582
-95% -$362K ﹤0.01% 404
2025
Q4 		$381K Buy
4,816
+3,070
+176% +$231K 0.01% 284
2025
Q3 		$114K Sell
1,746
-83
-5% -$4.05K ﹤0.01% 378
2025
Q2 		$72K Buy
+1,829
New +$59.9K ﹤0.01% 404

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Harvest Fund Management's IONS Position: Q2 2026 in Review

Harvest Fund Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 234 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

Harvest Fund Management first reported a position in IONS in Q2 2025 and has held it in 5 quarters since. The position peaked at $381K in Q4 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Harvest Fund Management held 234 shares of Ionis Pharmaceuticals worth $19K as of Q2 2026.
  • Harvest Fund Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Harvest Fund Management's portfolio in Q2 2026, its #407 holding.
  • Harvest Fund Management first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Harvest Fund Management's Ionis Pharmaceuticals position peaked at $381K in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.